1.
Orlowski TJ, Hill C, Garcia N, Jiminez V, Phillips C. Alternative Vismodegib Dosing Regimen for Patients with Basal Cell Carcinoma. J of Skin [Internet]. 2023Sep.15 [cited 2024Jul.16];7(5):1001-4. Available from: https://jofskin.org/index.php/skin/article/view/2070